Several companies in the biotech and medical technology sectors report new Form 4 filings, according to listings from Investing.com. The filings referenced include IRIDEX Corporation (for June 15), Arcutis Biotherapeutics Inc (for June 12), Lenz Therapeutics Inc (for June 15), Artiva Biotherapeutics Inc (for June 11), Design Therapeutics Inc (for June 11), Century Therapeutics Inc (for June 15), Quince Therapeutics Inc (for June 15), Apyx Medical Inc (for June 15), and MOBIX LABS, INC (for June 15). Form 4 is used to disclose transactions in company securities by insiders such as directors, officers, or beneficial owners, and may include buys, sells, or other changes in holdings. Across these sources, the common element is the reporting of Form 4 submissions tied to the specified dates for each company. The provided article excerpts do not include details of the underlying transactions, quantities, or prices, so those specifics cannot be confirmed from the information shown.